Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis
Trial Details
NCT Number NCT07856641
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: Sigma Theta Tau International Grant; Jerold B. Katz Endowment Fund
Conditions
(from sponsor)		 Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity
Related terms Motor Activity, Venous Thromboembolism
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov